의약품 관련 법령
Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-12-24 | 조회수 | 1,070 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM628903.pdf | ||
첨부파일 |
Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data
- 이전글 Post-Complete Response Letter Meetings Between FDA and ANDA Applicants Under GDUFA
- 다음글 The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers